X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank30
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-1.91
↓ 51% vs avg
Percentile
P30
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-1.26
Historical baseline
PeriodValueYoY Change
2025-1.91-78.9%
2024-1.07+30.9%
2023-1.54-89.0%
2022-0.82+0.9%
2021-0.82+61.6%
2020-2.15+16.1%
2019-2.56-6008.7%
2018-0.04+73.3%
2017-0.16+89.8%
2016-1.54-